|Bid||7.36 x 1300|
|Ask||7.39 x 2200|
|Day's range||7.11 - 7.88|
|52-week range||5.61 - 48.05|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2022 - 14 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.98|
ELV vs. GDRX: Which Stock Is the Better Value Option?
Yahoo Finance's Anjalee Khemlani breaks down quarterly earnings for Novavax and GoodRx as well as how the market is reacting.
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx second quarter 2022 earnings call. Joining me today are Doug Hirsch and Trevor Bezdek, our co-founders and co-chief executive officer; and Karsten Voermann, our chief financial officer.